Flutamide approved for prostate cancer.
D000813:Anilides / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005485:Flutamide / Q000008:administration & dosage / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives; D006728:Hormones / Q000008:administration & dosage; D006801:Humans; D016729:Leuprolide; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000813:Anilides; D006728:Hormones; D007987:Gonadotropin-Releasing Hormone; D005485:Flutamide; D016729:Leuprolide